Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Skeletal Radiology
Erschienen in: Skeletal Radiology 3/2023

29.06.2022 | Review Article

Bone and soft tissue tumors at the borderlands of malignancy

verfasst von: Julia Crim, Lester J. Layfield

Erschienen in: Skeletal Radiology | Ausgabe 3/2023

Einloggen, um Zugang zu erhalten

Abstract

This review examines findings of musculoskeletal neoplasms whose equivocal imaging and/or histopathologic features make it difficult to determine if they will show aggressive behavior. We include both intermediate tumors as defined by the World Health Organization (WHO), and a single low-grade malignancy, low-grade central osteosarcoma, which mimics a benign lesion on imaging and histology. Intermediate tumors are a broad category and are subdivided into tumors that have risk of local recurrence only, and ones that have a risk of distant limb and pulmonary metastases. Difficult intermediate musculoskeletal lesions include atypical cartilaginous tumor/grade 1 chondrosarcoma, atypical lipomatous tumor/grade 1 liposarcoma, and solitary fibrous tumor. We review diagnostic criteria, differential diagnosis, and recommendations for surveillance.
Literatur
1.
Fechner RE. The birth and evolution of American surgical pathology. In: J R, editor. Guiding the surgeon’s hand: the history of American surgical pathology. Washington, DC: Armed Forces Institute of Pathology; 1997. pp. 7–14.
2.
Miller TT. Bone tumors and tumorlike conditions: analysis with conventional radiography. Radiology. 2008;246(3):662–74.CrossRef
3.
Layfield LJ, Lenel JC, Crim JR, Renfrew D, Coulson WF, Wittels B, et al. Bone tumor radiograph review by pathologists prior to pathologic diagnosis: a receiver operator curve analysis of diagnostic utility. Oncol Rep. 1998;5(4):949–53.
4.
Gielen JL, De Schepper AM, Vanhoenacker F, Parizel PM, Wang XL, Sciot R, et al. Accuracy of MRI in characterization of soft tissue tumors and tumor-like lesions. A prospective study in 548 patients. Eur Radiol. 2004;14(12):2320–30.CrossRef
5.
Crim JR, Seeger LL, Yao L, Chandnani V, Eckardt JJ. Diagnosis of soft-tissue masses with MR imaging: can benign masses be differentiated from malignant ones? Radiology. 1992;185(2):581–6.CrossRef
6.
Douis H, Jeys L, Grimer R, Vaiyapuri S, Davies AM. Is there a role for diffusion-weighted MRI (DWI) in the diagnosis of central cartilage tumors? Skelet Radiol. 2015;44(7):963–9.CrossRef
7.
Douis H, Parry M, Vaiyapuri S, Davies AM. What are the differentiating clinical and MRI-features of enchondromas from low-grade chondrosarcomas? Eur Radiol. 2018;28(1):398–409.CrossRef
8.
Shannon BA, Ahlawat S, Morris CD, Levin AS, Fayad LM. Do contrast-enhanced and advanced MRI sequences improve diagnostic accuracy for indeterminate lipomatous tumors? Radiol Med. 2021;127(1):90–9.CrossRef
9.
Douis H, Davies MA, Sian P. The role of diffusion-weighted MRI (DWI) in the differentiation of benign from malignant skeletal lesions of the pelvis. Eur J Radiol. 2016;85(12):2262–8.CrossRef
10.
Bell SW, Kempson RL, Hendrickson MR. Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases. Am J Surg Pathol. 1994;18(6):535–58.CrossRef
11.
Peters WA 3rd, Howard DR, Andersen WA, Figge DC. Uterine smooth-muscle tumors of uncertain malignant potential. Obstet Gynecol. 1994;83(6):1015–20.CrossRef
12.
Jeffers MD, Oakes SJ, Richmond JA, Macaulay EM. Proliferation, ploidy and prognosis in uterine smooth muscle tumours. Histopathology. 1996;29(3):217–23.CrossRef
13.
Layfield LJ. Soft tissue neoplasm of uncertain malignant potential (STNUMP). In: Field AP, PIttman MB, Schmidt F, editors. International system for reporting soft tissue cytopathology. 1st ed. Geneva: World Health Organization; 2023.
14.
Bovee JV FA, Lazar AJ, Nielsen GP, Yoshida A. Soft tissue and bone tumours. WHO classification of tumours series. 5th ed. Lyon: International Agency for Research on Cancer; 2020.
15.
Bovee JV, Bloem JL, Flanagan AM, Lazar AJ, Nielsen GP, Yoshida A. Central atypical cartilaginous tumour/chondrosarcoma, grade 1. Soft Tissue and Bone Tumors. International Agency for Research on Cancer: Lyon; 2020. p. 370–2.
16.
Sbaraglia M, Dei Tos AP, Pedeutour F. Atypical lipomatous tumour/well-differentiated liposarcoma. Soft tissue and bone tumors. Lyon: International Agency for Research on Cancer; 2020. vol. 3, pp. 36–38.
17.
Welch HG, Black WC. Overdiagnosis in cancer. J Natl Cancer Inst. 2010;102(9):605–13.CrossRef
18.
Esserman LJ, Thompson IM Jr, Reid B. Overdiagnosis and overtreatment in cancer: an opportunity for improvement. JAMA. 2013;310(8):797–8.CrossRef
19.
Eichler M, Hentschel L, Richter S, Hohenberger P, Kasper B, Andreou D, et al. The health-related quality of life of sarcoma patients and survivors in Germany-cross-sectional results of a nationwide observational study (PROSa). Cancers (Basel). 2020;12(12).
20.
Geller DS, Hornicek FJ, Mankin HJ, Raskin KA. Soft tissue sarcoma resection volume associated with wound-healing complications. Clin Orthop Relat Res. 2007;459:182–5.CrossRef
21.
Moreira-Gonzalez A, Djohan R, Lohman R. Considerations surrounding reconstruction after resection of musculoskeletal sarcomas. Cleve Clin J Med. 2010;77 Suppl 1:S18-22.CrossRef
22.
Canter RJ, Qin LX, Ferrone CR, Maki RG, Singer S, Brennan MF. Why do patients with low-grade soft tissue sarcoma die? Ann Surg Oncol. 2008;15(12):3550–60.CrossRef
23.
Andreou D, Gilg MM, Gosheger G, Werner M, Hardes J, Pink D, et al. Metastatic potential of grade I chondrosarcoma of bone: results of a multi-institutional study. Ann Surg Oncol. 2016;23(1):120–5.CrossRef
24.
Fromm J, Klein A, Baur-Melnyk A, Knosel T, Lindner L, Birkenmaier C, et al. Survival and prognostic factors in conventional G1 chondrosarcoma. World J Surg Oncol. 2019;17(1):155.CrossRef
25.
Rupani A, Hallin M, Jones RL, Fisher C, Thway K. Diagnostic differences in expert second-opinion consultation cases at a tertiary sarcoma center. Sarcoma. 2020;2020:9810170.CrossRef
26.
Phemister D. Chondrosarcoma of Bone. Surg Gynecol Obstet. 1930;50:216–33.
27.
Ja E. A Review of the classification of bone tumors. Surg Gynecol Obstet. 1939;68:971–6.
28.
Lichtenstein L, Jaffe HL. Chondrosarcoma of Bone. Am J Pathol. 1943;19(4):553–89.
29.
Mirra JM, Gold R, Downs J, Eckardt JJ. A new histologic approach to the differentiation of enchondroma and chondrosarcoma of the bones. A clinicopathologic analysis of 51 cases. Clin Orthop Relat Res. 1985;201:214–37.CrossRef
30.
Skeletal lesions interobserver correlation among expert diagnosticians study G. Reliability of histopathologic and radiologic grading of cartilaginous neoplasms in long bones. J Bone Joint Surg Am. 2007;89(10):2113–23.CrossRef
31.
Eefting D, Schrage YM, Geirnaerdt MJ, Le Cessie S, Taminiau AH, Bovee JV, et al. Assessment of interobserver variability and histologic parameters to improve reliability in classification and grading of central cartilaginous tumors. Am J Surg Pathol. 2009;33(1):50–7.CrossRef
32.
Berend KR, Toth AP, Harrelson JM, Layfield LJ, Hey LA, Scully SP. Association between ratio of matrix metalloproteinase-1 to tissue inhibitor of metalloproteinase-1 and local recurrence, metastasis, and survival in human chondrosarcoma. J Bone Joint Surg Am. 1998;80(1):11–7.CrossRef
33.
de Andrea CE, San-Julian M, Bovee J. Integrating morphology and genetics in the diagnosis of cartilage tumors. Surg Pathol Clin. 2017;10(3):537–52.CrossRef
34.
Schrage YM, Lam S, Jochemsen AG, Cleton-Jansen AM, Taminiau AH, Hogendoorn PC, et al. Central chondrosarcoma progression is associated with pRb pathway alterations: CDK4 down-regulation and p16 overexpression inhibit cell growth in vitro. J Cell Mol Med. 2009;13(9A):2843–52.CrossRef
35.
Jia C, Crim J, Evenski A, Layfield LJ. Solitary fibrous tumor of bone developing lung metastases on long-term follow-up. Skelet Radiol. 2020;49(11):1865–71.CrossRef
36.
Murphey MD, Flemming DJ, Boyea SR, Bojescul JA, Sweet DE, Temple HT. Enchondroma versus chondrosarcoma in the appendicular skeleton: differentiating features. Radiographics. 1998;18(5):1213–37; quiz 1244-1215.CrossRef
37.
Crim J, Schmidt R, Layfield L, Hanrahan C, Manaster BJ. Can imaging criteria distinguish enchondroma from grade 1 chondrosarcoma? Eur J Radiol. 2015;84(11):2222–30.CrossRef
38.
Chung BM, Hong SH, Yoo HJ, Choi JY, Chae HD, Kim DH. Magnetic resonance imaging follow-up of chondroid tumors: regression vs. progression. Skelet Radiol. 2018;47(6):755–61.CrossRef
39.
Gajewski DA, Burnette JB, Murphey MD, Temple HT. Differentiating clinical and radiographic features of enchondroma and secondary chondrosarcoma in the foot. Foot Ankle Int. 2006;27(4):240–4.CrossRef
40.
Gelderblom H, Hogendoorn PC, Dijkstra SD, van Rijswijk CS, Krol AD, Taminiau AH, et al. The clinical approach towards chondrosarcoma. Oncologist. 2008;13(3):320–9.CrossRef
41.
Deckers C, de Leijer EM, Flucke U, de Rooy JWJ, Schreuder HWB, Dierselhuis EF, et al. Curettage and cryosurgery for enchondroma and atypical cartilaginous tumors of the long bones: Oncological results of a large series. J Surg Oncol. 2021;123(8):1821–7.CrossRef
42.
Andresen KJ, Sundaram M, Unni KK, Sim FH. Imaging features of low-grade central osteosarcoma of the long bones and pelvis. Skelet Radiol. 2004;33(7):373–9.CrossRef
43.
Unni KK, Dahlin DC, McLeod RA, Pritchard DJ. Intraosseous well-differentiated osteosarcoma. Cancer. 1977;40(3):1337–47.CrossRef
44.
Choong PF, Pritchard DJ, Rock MG, Sim FH, McLeod RA, Unni KK. Low grade central osteogenic sarcoma. A long-term followup of 20 patients. Clin Orthop Relat Res. 1996;(322):198–206.
45.
Franchi A, Bacchini P, Della Rocca C, Bertoni F. Central low-grade osteosarcoma with pagetoid bone formation: a potential diagnostic pitfall. Mod Pathol. 2004;17(3):288–91.CrossRef
46.
Yoshida A, Ushiku T, Motoi T, Shibata T, Beppu Y, Fukayama M, et al. Immunohistochemical analysis of MDM2 and CDK4 distinguishes low-grade osteosarcoma from benign mimics. Mod Pathol. 2010;23(9):1279–88.CrossRef
47.
Ellis JH, Siegel CL, Martel W, Weatherbee L, Dorfman H. Radiologic features of well-differentiated osteosarcoma. AJR Am J Roentgenol. 1988;151(4):739–42.CrossRef
48.
Bernard S, Walker E, Raghavan M. An approach to the evaluation of incidentally identified bone lesions encountered on imaging studies. AJR Am J Roentgenol. 2017;208(5):960–70.CrossRef
49.
Greenspan A. Bone island (enostosis): current concept–a review. Skelet Radiol. 1995;24(2):111–5.CrossRef
50.
Onitsuka H. Roentgenologic aspects of bone islands. Radiology. 1977;123(3):607–12.CrossRef
51.
Schweitzer ME, Levine C, Mitchell DG, Gannon FH, Gomella LG. Bull’s-eyes and halos: useful MR discriminators of osseous metastases. Radiology. 1993;188(1):249–52.CrossRef
52.
Ulano A, Bredella MA, Burke P, Chebib I, Simeone FJ, Huang AJ, et al. Distinguishing untreated osteoblastic metastases from enostoses using CT attenuation measurements. AJR Am J Roentgenol. 2016;207(2):362–8.CrossRef
53.
Elangovan SM, Sebro R. Accuracy of CT attenuation measurement for differentiating treated osteoblastic metastases from enostoses. AJR Am J Roentgenol. 2018;210(3):615–20.CrossRef
54.
Azar A, Garner HW, Rhodes NG, Yarlagadda B, Wessell DE. CT Attenuation values do not reliably distinguish benign sclerotic lesions from osteoblastic metastases in patients undergoing bone biopsy. AJR Am J Roentgenol. 2021;216(4):1022–30.CrossRef
55.
Fitzpatrick KA, Taljanovic MS, Speer DP, Graham AR, Jacobson JA, Barnes GR, et al. Imaging findings of fibrous dysplasia with histopathologic and intraoperative correlation. AJR Am J Roentgenol. 2004;182(6):1389–98.CrossRef
56.
Kinnunen AR, Sironen R, Sipola P. Magnetic resonance imaging characteristics in patients with histopathologically proven fibrous dysplasia-a systematic review. Skelet Radiol. 2020;49(6):837–45.CrossRef
57.
Laurino L, Furlanetto A, Orvieto E, Dei Tos AP. Well-differentiated liposarcoma (atypical lipomatous tumors). Semin Diagn Pathol. 2001;18(4):258–62.
58.
Kulkarni AS, Wojcik JB, Chougule A, Arora K, Chittampalli Y, Kurzawa P, et al. MDM2 RNA in situ hybridization for the diagnosis of atypical lipomatous tumor: a study evaluating DNA, RNA, and protein expression. Am J Surg Pathol. 2019;43(4):446–54.CrossRef
59.
Shannon BA, Ahlawat S, Morris CD, Levin AS, Fayad LM. Do contrast-enhanced and advanced MRI sequences improve diagnostic accuracy for indeterminate lipomatous tumors? Radiol Med. 2022;127(1):90–9.CrossRef
60.
Gupta P, Potti TA, Wuertzer SD, Lenchik L, Pacholke DA. Spectrum of fat-containing soft-tissue masses at MR imaging: the common, the uncommon, the characteristic, and the sometimes confusing. Radiographics. 2016;36(3):753–66.CrossRef
61.
Berkeley R, Okereke O, Malhotra K, Saifuddin A. The incidence and relevance of non-fatty components in trunk and extremity lipomatous soft tissue masses. Br J Radiol. 2021;94(1122):20201403.CrossRef
62.
Pressney I, Khoo M, Endozo R, Ganeshan B, O’Donnell P. Pilot study to differentiate lipoma from atypical lipomatous tumour/well-differentiated liposarcoma using MR radiomics-based texture analysis. Skelet Radiol. 2020;49(11):1719–29.CrossRef
63.
Skorpil M, Ryden H, Berglund J, Brynolfsson P, Brosjo O, Tsagozis P. Soft-tissue fat tumours: differentiating malignant from benign using proton density fat fraction quantification MRI. Clin Radiol. 2019;74(7):534–8.CrossRef
64.
Nardo L, Abdelhafez YG, Acquafredda F, Schiro S, Wong AL, Sarohia D, et al. Qualitative evaluation of MRI features of lipoma and atypical lipomatous tumor: results from a multicenter study. Skelet Radiol. 2020;49(6):1005–14.CrossRef
65.
Kransdorf MJ, Bancroft LW, Peterson JJ, Murphey MD, Foster WC, Temple HT. Imaging of fatty tumors: distinction of lipoma and well-differentiated liposarcoma. Radiology. 2002;224(1):99–104.CrossRef
66.
Weiss SW, Rao VK. Well-differentiated liposarcoma (atypical lipoma) of deep soft tissue of the extremities, retroperitoneum, and miscellaneous sites. A follow-up study of 92 cases with analysis of the incidence of “dedifferentiation.” Am J Surg Pathol. 1992;16(11):1051–8.CrossRef
67.
Moulin B, Messiou C, Crombe A, Kind M, Hohenberger P, Rutkowski P, et al. Diagnosis strategy of adipocytic soft-tissue tumors in adults: a consensus from European experts. Eur J Surg Oncol. 2022;48(3):518–25.CrossRef
68.
Gaskin CM, Helms CA. Lipomas, lipoma variants, and well-differentiated liposarcomas (atypical lipomas): results of MRI evaluations of 126 consecutive fatty masses. AJR Am J Roentgenol. 2004;182(3):733–9.CrossRef
69.
Suzuki R, Watanabe H, Yanagawa T, Sato J, Shinozaki T, Suzuki H, et al. PET evaluation of fatty tumors in the extremity: possibility of using the standardized uptake value (SUV) to differentiate benign tumors from liposarcoma. Ann Nucl Med. 2005;19(8):661–70.CrossRef
70.
Knebel C, Neumann J, Schwaiger BJ, Karampinos DC, Pfeiffer D, Specht K, et al. Differentiating atypical lipomatous tumors from lipomas with magnetic resonance imaging: a comparison with MDM2 gene amplification status. BMC Cancer. 2019;19(1):309.CrossRef
71.
Kito M, Yoshimura Y, Isobe K, Aoki K, Momose T, Suzuki S, et al. Clinical outcome of deep-seated atypical lipomatous tumor of the extremities with median-term follow-up study. Eur J Surg Oncol. 2015;41(3):400–6.CrossRef
72.
Gholami S, Cassidy MR, Kirane A, Kuk D, Zanchelli B, Antonescu CR, et al. Size and location are the most important risk factors for malignant behavior in resected solitary fibrous tumors. Ann Surg Oncol. 2017;24(13):3865–71.CrossRef
73.
Pasquali S, Gronchi A, Strauss D, Bonvalot S, Jeys L, Stacchiotti S, et al. Resectable extra-pleural and extra-meningeal solitary fibrous tumours: a multi-centre prognostic study. Eur J Surg Oncol. 2016;42(7):1064–70.CrossRef
74.
Badawy M, Nada A, Crim J, Kabeel K, Layfield L, Shaaban A, et al. Solitary fibrous tumors: clinical and imaging features from head to toe. Eur J Radiol. 2022;146:110053.CrossRef
75.
Hasegawa T, Hirose T, Seki K, Yang P, Sano T. Solitary fibrous tumor of the soft tissue. An immunohistochemical and ultrastructural study. Am J Clin Pathol. 1996;106(3):325–31.CrossRef
76.
Goldblum JR, Folpe AL, Weiss SW. Soft tissue tumors of intermediate malignancy of uncertain type. Soft tissue tumors. 7th ed. Philadelphia: Elsevier; 2020. pp. 1133–47.
77.
Salas S, Resseguier N, Blay JY, Le Cesne A, Italiano A, Chevreau C, et al. Prediction of local and metastatic recurrence in solitary fibrous tumor: construction of a risk calculator in a multicenter cohort from the French Sarcoma Group (FSG) database. Ann Oncol. 2017;28(8):1979–87.CrossRef
78.
Martin-Broto J, Mondaza-Hernandez JL, Moura DS, Hindi N. A comprehensive review on solitary fibrous tumor: new insights for new horizons. Cancers (Basel). 2021;13(12).
79.
Wignall OJ, Moskovic EC, Thway K, Thomas JM. Solitary fibrous tumors of the soft tissues: review of the imaging and clinical features with histopathologic correlation. AJR Am J Roentgenol. 2010;195(1):W55-62.CrossRef
80.
Hyodo R, Komada T, Takada A, Kawai H, Ito S, Nishida Y, et al. Solitary fibrous tumors in the extremities: imaging findings for six patients. Nagoya J Med Sci. 2015;77(1–2):167–78.
81.
Cipriano CA, Jang E, Tyler W. Sarcoma surveillance: a review of current evidence and guidelines. J Am Acad Orthop Surg. 2020;28(4):145–56.CrossRef
82.
Jurik AGHB, Weber K. Solitary Enchondromas–diagnosis and surveillance. Radiologe. 2020;60:S26-32.CrossRef
Metadaten
Titel
Bone and soft tissue tumors at the borderlands of malignancy
verfasst von
Julia Crim
Lester J. Layfield
Publikationsdatum
29.06.2022
Verlag
Springer Berlin Heidelberg
Erschienen in
Skeletal Radiology / Ausgabe 3/2023
Print ISSN: 0364-2348
Elektronische ISSN: 1432-2161
DOI
https://doi.org/10.1007/s00256-022-04099-1

Weitere Artikel der Ausgabe 3/2023

Skeletal Radiology 3/2023 Zur Ausgabe

Review Article

Ultrasound and MR imaging of peripheral nerve tumors: the state of the art

Review Article

Review of primary superficial soft tissue mesenchymal tumors of malignant or intermediate biological potential

Review Article

Bone marrow MR perfusion imaging and potential for tumor evaluation

Case Report

MRI of squamous cell carcinoma of the nail apparatus: report of 6 cases

Review Article

Bone and soft tissue tumors: clinicoradiologic-pathologic molecular-genetic correlation of novel fusion spindled, targetable-ovoid, giant-cell-rich, and round cell sarcomas

Review Article

Musculoskeletal oncology and thermal ablation: the current and emerging role of interventional radiology

Neu im Fachgebiet Radiologie

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

S3-Leitlinie zu Pankreaskrebs aktualisiert

23.04.2024 Pankreaskarzinom Nachrichten

Die Empfehlungen zur Therapie des Pankreaskarzinoms wurden um zwei Off-Label-Anwendungen erweitert. Und auch im Bereich der Früherkennung gibt es Aktualisierungen.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise